Adam Smith Conferences’
4th Annual International
Ukrainian Pharmaceutical Forum
17 – 19 Oktober 2011, Intercontinental Hotel, Kiew, Ukraine
Speakers:
• Maryna Buchma, External Relations Manager, GlaxoSmithKline Pharmaceuticals Ukraine
• Muralidharan Thrithala Kizhakekalam, Head of Representative Office, Dr. Reddy’s
Laboratories Ukraine
• Mykhailo Pasichnyk, Präsident, Pharmacy Professional Association Of Ukraine
• Natalia Takhtaulova, Head of Division on Licensing and Certification of Medicines
Herstellung, State Inspectorate for Quality Control of Medicines of the Ministry of Health
of Ukraine
• Nataliya Kasyanova, General Director, Med-Service Group
• Oleg Siarkevych, Business Development Director, Member of the Board, Farmak
• Oleksandr Melnyk, General Director, Falbi
• Olexiy Solovyov, Vorsitzende, State Administration of Ukraine for Medicinal Products
• Olga Baula, Consultant of Programs, Global Fund in Ukraine
• Representatives of the Management of the Healthcare Committee of the Verkhovna Rada
• Representatives of the Management of the Ukrainian Antimonopoly Committee
• Sergey Orlyk, Marketing Manager, Berlin-Chemie
• Sergiy Siomka, Director Department of Customs Control and Clearance, State Customs Service
of Ukraine
• Sergiy Khodos, Direktor, Fra-М
• Serhiy Mykhaylov, Head of Clinical Operations, Pfizer
• Stanislav Dyachenko, Direktor, Nizhpharm STADA Rep. Office Ukraine
• Svetlana Zavidova, Executive Director, Association of Clinical Trials Organizations (ACTO)
• Tatiana Bakhteeva, Head of the Committee for Healthcare, Verkhovna Rada of Ukraine
• Tetiana Buts, Direktor, Euroapteka
• Tetiana Talaieva, Deputy of Chairman, Central Ethics Committee of Ministry of Health of
Ukraine
• Thamarai Pandian, Head of Representative Office Ukraine & Eastern Europe, Unique
Pharmaceutical Laboratories
• Timur Bondaryev, Managing Partner, Arzinger
• Valentina Ocheretenko, Chair of the Board, Ukrainian Union of Patients’ Orginizations
“Health of Nation”
• Valery Stetsiv, Director of the Department of the Regulatory Policy in the Sphere of Circulation
of Medicines and Products in the Healthcare System, Ministry of Healthcare of Ukraine
• Vasyl Blikhar, General Director, State Expert Center MoH
• Vasyl Kornatskyi, Vorsitzende, Central Ethics Committee of Ministry of Health of Ukraine
• Victor Serdiuk, Präsident, All-Ukrainian Council for Patients Rights and Safety
• Viktor Pushkarev, Head of Region Russia, Ukraine and CIS, Orion Corporation, Finland
• Vitalii Usenko, Medical Director, Roche Ukraine
• Vladimir Dolot, Direktor, Municipal Health Insurance Fund of the City of Kyiv
• Vladimir Dudka, Chairman of the Supervisory Board, Alba-Ukraine
• Vladimir Ignatov, Executive Director, AIPM Ukraine
• Volodymyr Lapshyn, Head of the Сhildren’s Allergy and Immune Rehabilitation Department,
Institute of Pediatrics, Obstetrics and Gyneacology at the NAMS of Ukraine
• Yevgen Sova, Commercial Director, Borschahivskiy Chemical-Pharmaceutical Plant
Die Informationen auf dieser Seite sind für wissenschaftliche Zwecke bestimmt, pädagogisch, und allgemeine Informationszwecke. Klinische Ansätze, Verfügbarkeit, und der regulatorische Status kann je nach Land variieren, Institution, und medizinische Indikation. Für individuelle medizinische Entscheidungen, Leser sollten sich an qualifiziertes medizinisches Fachpersonal und akkreditierte medizinische Zentren wenden.
Dieser Artikel wurde von der NBScience-Redaktion im Rahmen der klinischen Forschung erstellt, Biotechnologie, und internationale medizinische Informationen.
0 Kommentare